Crossmark

Reply to the comment on “Vibegron 50 mg is the optimal algorithm in the pharmacologic management of overactive bladder: outcomes from a systematic review and meat-analysis”

Crossref DOI link: https://doi.org/10.1007/s11255-021-02896-6

Published Online: 2021-05-26

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jian, Zhongyu

Yuan, Chi

Li, Hong

Zhang, Wei

Wang, Kunjie https://orcid.org/0000-0001-8289-2791
License Information

Text and Data Mining valid from 2021-05-26

Version of Record valid from 2021-05-26
More Information

Article History

Received: 18 May 2021

Accepted: 22 May 2021

First Online: 26 May 2021

Declarations

:

: The authors of this article as well as all the included studies declare that they have no conflict of interest.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below